NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,007,417
+5.5%
11,246
+0.3%
0.03%
+12.0%
Q2 2023$954,505
+3.1%
11,211
+0.2%
0.02%
+4.2%
Q1 2023$926,221
+151.5%
11,193
+139.0%
0.02%
+140.0%
Q4 2022$368,318
-32.9%
4,683
-36.8%
0.01%
-28.6%
Q3 2022$549,000
-1.6%
7,411
-13.4%
0.01%
+7.7%
Q2 2022$558,000
+3.9%
8,555
+0.8%
0.01%
+8.3%
Q1 2022$537,000
+19.6%
8,489
+0.2%
0.01%
+33.3%
Q4 2021$449,000
-24.4%
8,472
+0.6%
0.01%
-25.0%
Q3 2021$594,000
+4.9%
8,419
-0.8%
0.01%
+20.0%
Q2 2021$566,000
-39.9%
8,486
+0.1%
0.01%
-41.2%
Q1 2021$941,000
-54.6%
8,478
-51.4%
0.02%
-39.3%
Q4 2020$2,073,000
+32.0%
17,458
-0.4%
0.03%
+27.3%
Q3 2020$1,570,0000.0%17,5330.0%0.02%0.0%
Q2 2020$1,570,000
-10.5%
17,533
-0.4%
0.02%
-18.5%
Q1 2020$1,754,000
+5.5%
17,600
+21.6%
0.03%
-10.0%
Q4 2019$1,663,000
-8.9%
14,4760.0%0.03%
-25.0%
Q3 2019$1,826,000
+3.9%
14,476
-0.9%
0.04%
-2.4%
Q2 2019$1,757,000
+121.3%
14,604
+60.9%
0.04%
+192.9%
Q1 2019$794,000
-18.7%
9,075
-7.1%
0.01%
-12.5%
Q4 2018$977,000
-12.5%
9,770
+0.3%
0.02%
-5.9%
Q3 2018$1,116,000
+21.3%
9,743
-5.0%
0.02%
+21.4%
Q2 2018$920,00010,2610.01%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders